What products does Zhengda Tianqing have?

What products does Zhengda Tianqing have?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is one of China's leading pharmaceutical companies, focusing on product development and production in the fields of liver diseases, anti-tumor, respiratory diseases, cardiovascular and cerebrovascular diseases, etc. In recent years, Chia Tai Tianqing has occupied an important position in the pharmaceutical market with its research and development capabilities of innovative drugs and generic drugs. The following are the main product categories and representative drugs of Zhengda Tianqing.

1. Main product categories of Zhengda Tianqing

2. Analysis of popular products of Zhengda Tianqing

1. Tianqingganmei (Magnesium Isoglycyrrhizinate Injection)

Tianqing Ganmei is one of the flagship products of Zhengda Tianqing, which is mainly used to treat chronic hepatitis and liver fibrosis. Its active ingredient, magnesium isoglycyrrhizinate, has significant anti-inflammatory and hepatoprotective effects, and its clinical effects are well recognized. In recent years, as the number of patients with liver diseases has increased, the market demand for this product has continued to grow.

2. Anlotinib (Focovit)

Anlotinib is a multi-target tyrosine kinase inhibitor indicated for the treatment of advanced non-small cell lung cancer and soft tissue sarcoma. As an anti-tumor drug independently developed by Chia Tai Tianqing, anlotinib has become an important choice in the field of domestic tumor treatment due to its efficacy and safety.

3. Tiotropium bromide powder spray (Tianqingsule)

Tianqingsule is an important product of Chia Tai Tianqing in the field of respiratory diseases and is mainly used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). With the increase in air pollution and smoking, the number of COPD patients is rising, and the market prospect of this product is broad.

3. R&D and market performance of Zhengda Tianqing

Chia Tai Tianqing has invested heavily in the research and development of innovative drugs in recent years, especially in the fields of anti-tumor and liver diseases. Many of its products have passed consistency evaluations and won bids for national centralized procurement, further expanding their market share. The following is the market performance of some products of Zhengda Tianqing:

4. Future development direction

Chia Tai Tianqing will continue to focus on the research and development of innovative drugs in the future, especially in the fields of anti-tumor and biological drugs. At the same time, the company plans to introduce more products to overseas markets through its internationalization strategy. In addition, Zhengda Tianqing will also strengthen digital marketing to increase product coverage in the terminal market.

In summary, Chia Tai Tianqing’s products cover multiple therapeutic areas, especially in liver diseases and anti-tumor drugs, with significant advantages. With the rapid development of the pharmaceutical industry, Chia Tai Tianqing is expected to further consolidate its market position through innovation and internationalization strategies.